National Institutes of Health
The National Institutes of Health (NIH) is a US federal agency funding biomedical research grants & programs.
Unlock Funding: Fight Opioid Crisis with Tech
US small businesses with tech expertise can get funding to develop innovative solutions for the opioid epidemic. Your groundbreaking technology could help save lives and offer hope to affected communities.
Unlock Funding to Fight Opioid Crisis Tech!
US small businesses with tech expertise can receive funding to develop innovative solutions for the national opioid crisis. This grant supports R&D to create science-based tools and technologies offering new hope.
NIH Grant: Fund Pain Relief Research & Innovation
U.S. researchers and institutions can secure funding to develop innovative, non-addictive pain treatments and advance our understanding of chronic pain. This initiative aims to combat the opioid crisis by accelerating the discovery and testing of promising new therapies.
NIH Grant: Fund Back Pain Research & Innovation
This NIH program supports innovative research into the causes of acute and chronic back pain, aiming to uncover new treatment targets. Researchers and institutions are invited to propose multidisciplinary projects for deep patient phenotyping and discovery.
Unlock Funding for Pain Research & New Therapies
Are you a research institution or academic/industry partner involved in pain management? This funding supports a central hub for groundbreaking clinical trials and biomarker studies to develop novel pain therapeutics.
NIH Grant: Fund Your Pain Research & Innovation
This NIH grant opportunity funds a Data Coordinating Center to manage and analyze crucial data for pain research, including clinical trials and biomarker studies. Eligible entities can receive funding to support the infrastructure and statistical expertise needed for groundbreaking pain therapeutic development.
Fund Your Back Pain Research: NIH Grants Available
This NIH program provides funding for Phase 2 clinical trials focused on developing innovative solutions for the opioid crisis and back pain management. Researchers and organizations with a focus on pain relief and opioid alternatives are encouraged to apply.
NIH Grants: Fund Your Pain Treatment Innovation
Are you a research institution or technology developer focused on solving the opioid crisis through pain management? This NIH program funds innovative research and technology development to discover and test non-addictive pain treatments and understand chronic pain.
NIH Funding: Advance Your Biomedical Research
This NIH grant supports innovative, exploratory research using Xenopus as a model organism to develop new tools and resources for understanding development and cell biology. It's ideal for novel projects breaking new ground, not for long-term, established research.
NIH Grant: Fund Your Xenopus Research!
Biomedical researchers using Xenopus as a model organism can receive funding to develop new genetic tools or genomic resources. This grant supports projects that advance the understanding of development, organogenesis, and cell biology.
Get Funding for Maternal & Child Health Research
This grant supports community-based research projects focused on improving maternal and child health outcomes, especially within minority communities. Funds are available for capacity building and implementing innovative health interventions.
Unlock Cancer Research Funding: Specimen Banking Grants
Are you involved in NCI-supported clinical trials? This grant offers funding to continue supporting cooperative group banks that collect, store, and distribute vital human specimens and data for cancer research. Access high-quality resources to develop and validate crucial biomarkers for diagnosis, prognosis, and treatment.
Get Funding for Cancer Biomarker Research
This grant funds organizations developing and validating biomarkers for early cancer detection, risk assessment, and diagnosis. It specifically supports data management, statistical analysis, and resource centers for a national cancer research network.
Secure Funding for Cancer Biomarker Research!
Are you a research laboratory focused on developing and validating new tools for early cancer detection? This grant offers funding to support your critical work in advancing cancer diagnostics and risk assessment as part of a national network.
Get Funding for Cancer Biomarker Research & Development
This grant funds research centers focused on validating biomarkers for early cancer detection, risk assessment, and diagnosis. Businesses and institutions can secure funding to develop and refine tools that significantly improve cancer screening and patient outcomes.
NIH Grants: Boost Your Biomedical Research Funding
This NIH program offers funding for collaborative biomedical research projects between U.S. and Brazilian institutions. Focus areas include infectious diseases, cancer, neurological disorders, and more, with clinical trials being optional.
NIH Grant: Fight HIV/AIDS Fueled by Drug Use
This NIH grant is for researchers and organizations focused on understanding and combating the link between drug abuse and the HIV/AIDS epidemic in vulnerable US populations. Funding supports studies to develop effective interventions, improve prevention strategies, and enhance the health and well-being of those affected.
Unlock Research Funding: Fight HIV/AIDS & Drug Abuse
This grant supports research to understand and combat the link between drug abuse and the HIV/AIDS epidemic in vulnerable US populations. Secure funding to develop interventions that prevent new infections and improve health outcomes.
Fund Your Blood Science Research Career
Physician scientists in blood science can get funding to transition from mentored research to independent faculty positions, with potential for a follow-on grant to launch your own lab. This award supports your growth into an independent investigator.
NIH Grant: Fund Your Blood Science Research Career
This NIH award supports physician scientists transitioning to independent research careers in blood science, providing funding for mentored research and the launch of independent clinical trials.